Current status: 1095 hESC lines, 7294 hiPSC lines, and 182 clinical studies, and 2396 certificates
Monthly statistic from Aug 1, 2025
Posted on August 1, 2025
total lines | 8389 |
hESC lines | 1095 |
hiPSC lines | 7294 |
derivation countries | 50 |
projects | 325 |
providers | 999 |
clinical studies | 182 |
subclones | 3648 |
certificates | 2396 |
cell line certificates | 2244 |
project certificates | 152 |